Collegium Pharmaceutical Receivables

Collegium Pharmaceutical (COLL) currently reports a receivables of $290M as of June 2026. That compares with $210M in the prior-year period — up 33.8% year over year. Use the charts on this page to explore Collegium Pharmaceutical's receivables history and peer comparisons.

Collegium Pharmaceutical's receivables increased from $210M to $290M — a 33.8% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Collegium Pharmaceutical reported $290M in receivables as of June 2026. That compares with $210M in the prior-year period — up 33.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $290M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Collegium Pharmaceutical, and consider following COLL for alerts when major investors trade the stock.

Collegium Pharmaceutical is classified in the Healthcare sector. On receivables, it currently shows $290M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing COLL with unrelated industries.